MedMira Inc. MMIRF
Set alert
0.04 USD 0.00 0.00%
At close · Nov 2
0.035 Day range 0.035
0.0012 52-week range 0.95
- YTD
- +191.67%
- 1 year
- -30.00%
- Open
- 0.035
- Prev close
- 0.035
- Mkt cap
- 24.56M
- Vol
- 20.00K
- Avg vol
- 1.10K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.035
- High
- 0.035
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| RSI: Oversold | Oct 30, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
News
- MedMira Reports Third Quarter Results FY2026
- MedMira Reports Second Quarter Results FY2025
- MedMira Reports First Quarter Results FY2026
- MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
- Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
- MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
- MedMira Reports Second Quarter Results FY2025
- MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
- MedMira Reports Second Quarter Results FY2025
- MedMira Announces Partnership with MediGroup Physician Services in the United States
Your note
Sign in to keep a note on MMIRF — it syncs with the Stock Master app.